NEW YORK, NY / ACCESSWIRE / November 20, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Golden Star Resources Ltd (NYSE: GSS), Silicon Graphics International Corp (NASDAQ: SGI), Asterias Biotherapeutics Inc (NYSE: AST) and Affimed NV (NASDAQ: AFMD). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

GSS Research Package: http://www.traders-choice.com/pdf?s=GSS

SGI Research Package: http://www.traders-choice.com/pdf?s=SGI

AST Research Package: http://www.traders-choice.com/pdf?s=AST

AFMD Research Package: http://www.traders-choice.com/pdf?s=AFMD

============

Highlights from today's reports include:

On Thursday, November 19, 2015, the NASDAQ Composite ended at 5,073.64, down 0.03%, the Dow Jones Industrial Average edged 0.02% lower, to finish the day at 17,732.75, and the S&P 500 closed at 2,081.24, down 0.11%.

- Golden Star Resources Ltd's stock edged lower by 3.95% to close Thursday's session at USD 0.19. The company's shares oscillated between USD 0.19 and USD 0.21. The stock has a 52-week low of USD 0.16 and a 52-week high of USD 0.42. The stock recorded a trading volume of 0.47 million shares, which was below its 50-day daily average volume of 0.56 million shares and lower than its 52-week average volume of 1.27 million shares. Over the last three days, Golden Star Resources Ltd's shares have declined by 10.65% and in the past one week it has moved down 7.42%. Additionally, the stock is trading at a price to cash flow ratio of 1.82 and price to sales ratio of 0.19. The stock is trading below its 52-day and 200-day moving average of USD 0.22 and USD 0.25, respectively. The company has a market cap of USD 49.93 million.

- The stock of Silicon Graphics International Corp gained 4.43% to close Thursday's session at USD 5.42. The shares of the company moved in the range of USD 5.15 and USD 5.58. A trading volume of 0.26 million shares was recorded, which was lower than its 150-day daily average volume of 0.32 million shares and below its 52-week average volume of 0.28 million shares. Over the last five days, Silicon Graphics International Corp's shares have advanced 3.63% and in the past one month, it has gained a momentum of 28.74%. Additionally, over the last three months, the stock has advanced 13.87% while in the past six months, the shares have registered a loss of 21.68%. The company has returned 27.83% in the past one month, and 9.05% in the last three months, on a compounded total return basis. The stock is at a price to book ratio of 3.87. The historical PB ratio is near to 4.31. Further, the stock is trading at a price to sales ratio of 0.34.

- Asterias Biotherapeutics Inc's stock increased by 3.73% to close Thursday's session at USD 5.00. The company's shares fluctuated in the range of USD 4.85 and USD 5.29. The 52-week range for the stock is USD 3.05 - USD 15.10. A total of 0.16 million shares exchanged hands, which surpassed its 50-day daily average volume of 0.14 million shares but was below its 52-week average volume of 0.19 million shares. Over the last three days Asterias Biotherapeutics Inc's shares have advanced 5.04% and in the past one week it has moved up 6.38%. Furthermore, over the last three months, the stock has gained 34.41% while in the past six months, the shares have shed 54.50%. The company has a Price/Sales (TTM) ratio of 45.01 and Price/Book (MRQ) ratio of 4.30. The company has a market cap of USD 188.21 million.

- Affimed NV's stock slipped by 1.65% to close Thursday's session at USD 5.95. The company's shares oscillated between USD 5.91 and USD 6.27. The stock recorded a trading volume of 0.14 million shares, which was below its 50-day daily average volume of 0.31 million shares and lower than its 52-week average volume of 0.21 million shares. The stock is trading below its 50-day and 200-day moving average of USD 6.58 and USD 10.34. Over the last five days, Affimed NV's shares have declined by 4.80% and in the past one month, it has lost 17.82%. The company has returned 5.31% in the past one year, on a compounded total return basis. The stock has a Price/Sales (TTM) multiple of 25.40 and a Price/Book (MRQ) multiple of 3.20. The clinical-stage biopharmaceutical company has a market cap of USD 176.92 million.

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice